EVRG — Evergy, Inc.

Sentiment as of 2026-09-13 is best described as indifferent-to-mildly-constructive, and the gap is the story. Fundamentals keep beating — Q2 2026 GAAP EPS of $0.91 vs $0.74 a year ago, adjusted EPS $0.88 vs $0.81 consensus, FY26 guidance ($4.14–$4.34) and the 6–8%+ through-2030 growth target both reaffirmed, and a constructive data-center/large-load pipeline behind the LLPS tariff. Yet the stock has done nothing: -0.42% vs the 20-day, -2.55% vs the 50-day, -2.04% over one month, -2.66% over three months, -1.22% over six. That is a utility being traded as a duration instrument, not an earnings story — the $600M 6.4% note issue in late August and a $2.78 annualized dividend yielding 3.33% (below a ~4% risk-free rate) keep the stock anchored to the rate curve. Note the data conflict: FMP's hard snapshot shows a 'Hold' consensus (7 buy / 9 hold / 2 sell, $92.25 average target), while the live brief describes a 'Moderate Buy' at $90.60–$91.95 — I weight the harder FMP numbers, but either way the sell side sees ~13% upside the market has so far declined to pay for.

Revenue is in a stable, mildly accelerating 5% band, with the usual utility seasonality on top. Q2 2026 revenue of $1,500.1M was +5.1% YoY (vs $1,426.9M in Q2 2025); Q1 2026 was +5.5% YoY ($1,443.7M vs $1,368.8M); Q4 2025 was +9.5% YoY ($1,328.2M vs $1,213.1M); the only negative print in the window was Q3 2025 at -1.4% YoY ($1,795.9M vs $1,822.2M), and Q3 is the seasonal peak, so that softness is weather/volumetric rather than structural. Margins are genuinely expanding, not just revenue-line growth: operating margin was 25.4% in Q2 2026 vs 23.4% in Q2 2025 (+200bps) and 22.1% vs 20.9% in Q1 2026 (+116bps), consistent with rate-base recovery and cost pass-throughs. EPS is inflecting harder than either line: Q2 2026 diluted EPS $0.91 vs $0.74 (+23%), Q1 2026 $0.64 vs $0.54 (+19%), with net income $215.0M vs $171.3M (+25.5%). The offset is the cash side — TTM free cash flow is roughly -$1.41B, with capex stepping up sharply (Q2 2026 capex $959.9M vs $627.3M a year prior), because this is a rate-base build-out cycle, not an earnings-quality problem. Earnings quality actually checks out: the accruals ratio as of 2026-06-30 was -0.38% (operating cash flow running ahead of net income), the healthier direction. Verdict: stable-to-modestly-accelerating on revenue and margin, with an EPS tailwind from capital recovery — a blip-free trend, with the caveat that reported growth depends on regulatory recovery keeping pace with the capex.

Fair-to-rich, not cheap. As of 2026-09-13 the stock carried a 20.30x TTM P/E against a 5-year average of 17.94x — a ~13% premium to its own history — and 3.10x TTM P/S against a 5-year average of 2.56x, a ~21% premium. On forward numbers it looks slightly better but not cheap: $81.62 / $4.256 FMP next-FY EPS = 19.2x, and $81.62 / the $4.24 midpoint of 2026 guidance = 19.25x. PEG of 1.95 looks alarming but is mostly an artifact of applying a growth-adjusted lens to a regulated utility that structurally trades at high multiples on modest growth; against the reaffirmed 6–8%+ EPS CAGR, 19x forward is a rich-but-defensible regulated-electric multiple, not an outlier versus the peer group. P/B of 1.84x against an 8.4% ROE and 4.2% ROIC is the more demanding number — the market is capitalizing a regulated asset base at a premium to book while returns remain below the sector's typical allowed 9.5–10% ROE, i.e., it is paying for rate-base growth and eventual ROE improvement. EV/EBITDA of 12.69x sits at the high end of the normal 10–13x regulated utility band. The 3.33% dividend yield is the tell: below a ~4% risk-free rate, it offers no income cushion, so the valuation has to be earned through growth rather than carry. My read: roughly 10–15% rich versus its own 5-year norm and at best in line with peers — the deterministic 'Rich vs. its own history' tag is accurate.

The interesting wrinkle is that this stock is not pricing in growth that hasn't shown up — it is ignoring growth that already has. TTM EPS has climbed (Q2 2026 $0.91 vs Q2 2025 $0.74; Q1 2026 $0.64 vs $0.54) while the share price is down 1.22% over six months and 2.66% over three, so the forward multiple has been compressing as earnings arrive. That is the classic regulated-utility pattern: the multiple is set by the discount rate and the 10-year Treasury, not by the quarterly EPS print, so an earnings beat alone will not re-rate the stock. Practically, that means (a) do not treat the ~13% gap to the $92.25 sell-side consensus as a near-term catalyst — it has persisted through multiple beats and will likely persist until rates move or a rate case lands favorably; and (b) the asymmetry is on the macro side, not the earnings side. If you are buying EVRG for an EPS-beat-and-rerate thesis, you have the wrong instrument. If you are buying a 6–8%+ EPS compounder with a 3.33% dividend and a low beta at roughly fair value, the setup makes more sense — but the entry price matters more than the earnings trajectory.

Neutral-to-soft and range-bound as of 2026-09-13. RSI(14) at 45.93 is dead-neutral — no oversold capitulation and no momentum thrust, so there is no technical urgency in either direction. The stock is marginally below its 20-day (-0.42%) and more meaningfully below its 50-day (-2.55%), which flags a slow drift lower within the range, while the +1.07% vs the 200-day says the longer-term uptrend is still intact. Returns of +0.1% (1wk), -2.04% (1mo), -2.66% (3mo), -1.22% (6mo) describe a stock grinding sideways-to-down, not breaking down. The 52-week band of $71.20–$88.62 puts the price at roughly the 60th percentile, i.e., lower-middle of the range with room to the $88.62 high. Entry-timing implication: there is no technical edge here. Nothing says 'buy the dip' (RSI is not near 30, no flush) and nothing says 'chase' (price is below both short moving averages). A pullback toward the mid-$70s or the 200-day, or alternatively a decisive reclaim of the 50-day, would be the two setups worth acting on; right now it is simply a waiting game, and a low-beta (0.51) stock like this gives you plenty of time to wait for one of them.

• Interest rates / duration: Evergy is a capital-intensive, rate-sensitive bond proxy with beta of 0.51. The 3.33% dividend yield sits below a roughly 4% risk-free rate, so the stock offers a negative yield spread — it re-rates upward only if the rate curve falls further, and is capped while rates stay elevated.
• Financing cost and capital structure: $12.32B of long-term debt (up from $11.05B at year-end 2023) plus a current liabilities line that jumped from $4.22B in Q1 2026 to $5.75B in Q2 2026, funded via the late-August $600M 6.4% note issue and the retirement of a $500M bridge loan. Every incremental basis point of funding cost directly pressures the 6–8% EPS growth target.
• Regional load growth from data centers and large industrial customers: Evergy's LLPS tariff lets it charge premium rates to high-load customers that cover their own infrastructure, expanding rate base without pushing costs onto retail ratepayers — a genuine secular tailwind unique to favorably-located utilities.
• Regulatory environment in Kansas and Missouri: both jurisdictions are generally constructive, and timely recovery of capital through rate cases is the single biggest determinant of whether the 6–8%+ EPS CAGR (and >8% in 2028–2030) is achievable.
• Sector rotation and utility relative value: with the broader market focused on growth/AI themes, regulated utilities trade as defensive ballast — they underperform in risk-on tape and attract flows when investors want low-volatility, income-oriented exposure, which currently competes poorly with short-duration yields.
• Heavy capex cycle: capex is annualizing toward ~$3.4B in 2026 (Q2 2026 alone was $959.9M), versus roughly $2.8B in 2025 — this builds rate base and future earnings, but it also means persistent negative free cash flow and a recurring need for external financing, including potential equity issuance.

• Q3 2026 earnings, expected late October / early November 2026 — the key question is whether the Q1/Q2 margin expansion and adjusted-EPS beats continue into the seasonally strong quarter, plus any update on winter preparedness and the large-load pipeline.
• Execution of at least one additional large-customer Electric Service Agreement before the end of 2026 — management has signaled high confidence, and each signed ESA de-risks and extends the rate-base growth runway.
• Kansas and Missouri rate case filings and outcomes, which determine whether the capital being spent actually converts into allowed returns on a timely basis.
• Federal Reserve rate path — with a 3.33% dividend yield below the risk-free rate, any meaningful easing would compress the yield spread and is arguably the single most powerful re-rating catalyst for this stock.
• Progress and eventual in-service of the 710MW Sumner County combined-cycle gas plant (construction began May 2026), which supports both reliability and future rate base.
• Dividend growth announcements (typically with the January board action) — a raise in line with the 6–8% EPS growth target would reinforce the total-return case.

• Rate sensitivity: with a 3.33% yield below a ~4% risk-free rate, EVRG offers no income cushion against rising yields — the stock's flat-to-lower performance over the past 3 and 6 months despite earnings beats shows exactly this dynamic at work.
• Regulatory lag or disallowance: the entire 6–8%+ EPS growth thesis depends on commissions in Kansas and Missouri approving timely recovery of an accelerating capex program. A single adverse rate case or a disallowance would break the growth algorithm that justifies a 19x forward multiple.
• Persistently negative free cash flow: TTM FCF is roughly -$1.41B and capex is still climbing. The dividend ($2.78 annualized, ~66% of the 2026 guidance midpoint) plus the capex program are being funded with debt and potentially equity, which risks dilution and rising interest expense.
• Balance sheet strain at the margin: long-term debt of $12.32B, total liabilities of $25.08B against $10.22B of equity (D/E 1.61), cash of only $21.8M, a current ratio of 0.36, and a current-liabilities line that jumped $1.53B in one quarter (Q1 to Q2 2026). Structural for a utility, but it leaves little slack if anything goes wrong.
• Load-growth concentration risk: a meaningful share of the forward rate-base story rests on large-load/data-center customers. A pause in data-center capex, a customer bankruptcy, or a delay in ESA signings would hit both the growth rate and the narrative simultaneously.
• Weather and storm costs: revenue and EPS remain sensitive to volumetric weather and to uninsured storm restoration expenses, which can create one-off misses in an otherwise steady regulated model.
• Weak absolute returns on capital: ROIC of 4.2% and ROE of 8.4% are below what the 1.84x P/B implies the market expects, leaving the stock vulnerable if returns do not improve toward allowed levels.

Evergy is a decent regulated utility priced at a full price, and that combination argues for patience rather than a purchase at $81.62. The operating business is doing what it should — revenue +5.1% YoY in Q2 2026, operating margin expanding ~200bps, EPS up 23% YoY, guidance reaffirmed at $4.14–$4.34 with 6–8%+ growth through 2030, and a genuine data-center/large-load tailwind via the LLPS tariff. But you are paying 19.2x forward and 20.3x trailing earnings against a 5-year average of 17.94x, 1.84x book on an 8.4% ROE, and 12.69x EV/EBITDA, for a 3.33% dividend yield that sits below the risk-free rate. My own intrinsic estimate of $83.50 is only about 2% above the 2026-09-13 price — this is not a mispriced asset, and the ~13% gap to the $92.25 consensus target is a bet on rates, not on the company. With negative TTM free cash flow of ~$1.41B and an accelerating capex program that needs external financing, there is no valuation cushion if a rate case or the rate curve goes the wrong way. Watch it, wait for either a better entry (mid-$70s / 200-day) or a decisive turn in the rate environment; do not chase a low-beta utility that is already trading above its own historical multiple.

Method: a three-way blend, all as of 2026-09-13. (1) 19.0x forward P/E — a modest premium to the stock's own 5-year average of 17.94x, justified by the reaffirmed 6–8%+ EPS CAGR but deliberately held below the current 19.2x forward / 20.3x trailing multiple — applied to my 2027E EPS of ~$4.40, which blends FMP's thin next-FY consensus of $4.256 with management's guidance arithmetic off the $4.24 midpoint of 2026 guidance, giving $83.60. (2) 12.5x forward EV/EBITDA on ~$2.70B of forward EBITDA (FMP's next-FY revenue estimate of $6.28B at the TTM-implied ~43% EBITDA margin), less ~$14.3B of net debt and across ~230.5M shares, giving ~$84.34. (3) A 3.35% fair dividend yield on the $2.78 annualized dividend, giving $82.99. The three converge tightly near $83.5, so I use $83.50 — roughly 2% above the $81.62 price on 2026-09-13, and far below the $92.25 sell-side consensus, which I think embeds a rate-cut outcome rather than a fundamental re-rating.